RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Discovery of novel chiral 3o-SMe pyrrolidine as extracellular regulated kinase (ERK) inhibitors
Boga, S., Alhassan, A.-B., Cooper, A., Doll, R., Shih, N.-Y., Deng, Y., Shipps, G., Sun, R., Desai, J., Zhu, H., Patel, M., Muppalla, K., Zhu, L., Nan, Y., Wang, J., Gao, X., Gudipati, S., Kelly, J., Siddiqui, A., ... Bishop, R. (2016). Discovery of novel chiral 3o-SMe pyrrolidine as extracellular regulated kinase (ERK) inhibitors. Abstracts of Papers of the American Chemical Society, 251.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.
